New Zealand becomes second country to approve MDMA for PTSD treatment
- New Zealand approves pharmaceutical-grade MDMA for treating adults with severe post-traumatic stress disorder PTSD.
- Medsafe, New Zealand’s medicines regulator, allows two psychiatrists to prescribe MDMA after a year-long regulatory process.
- The treatment combines MDMA with psychotherapy in controlled clinical settings, with patients not allowed to take the drug home.
- New Zealand becomes the second country to allow MDMA-assisted therapy for PTSD, after Australia approved it in 2023.
Source: euronews.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
